Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.
November 2023 in “Journal of Investigative Dermatology” This study utilized single-cell RNA sequencing and ATAC sequencing to analyze peripheral blood mononuclear cells from 6 mild alopecia areata (AA) patients, 5 severe AA patients, and 5 healthy controls, identifying 16 unique cell clusters among 32,084 cells. The research highlighted that over 80% of these cell types shared open chromatin regions linked to nine key transcription factors involved in various immune functions, such as T cell activation, dendritic cell maturation, and B cell maturation. The findings provide a detailed view of the transcriptional and epigenetic differences between mild and severe AA, offering insights for future research and potential therapeutic targets.
February 2026 in “Journal of Allergy and Clinical Immunology” Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.
23 citations
,
July 2023 in “Proceedings of the National Academy of Sciences” CD8+ T cells drive alopecia areata, while regulatory T cells are protective.
4 citations
,
June 2025 in “Cell Reports”